Literature DB >> 8143827

Respiratory muscle function and exercise capacity in multiple sclerosis.

K Foglio1, E Clini, D Facchetti, M Vitacca, S Marangoni, M Bonomelli, N Ambrosino.   

Abstract

Patients with multiple sclerosis (MS) show a poor exercise tolerance. A reduction in respiratory muscle strength has also been reported. The purpose of this study was to evaluate whether reduction in exercise tolerance was related to respiratory muscle dysfunction. Twenty four multiple sclerosis patients (mean +/- SD age: 48 +/- 9 yrs, duration of illness 12.2 +/- 6 yrs, severity of illness as assessed by Expanded Disability Scale Score (EDSS) 5.3 +/- 2), underwent detailed evaluation of lung function tests, arterial blood gas analysis, respiratory muscle strength and endurance, and exercise test on an arm ergometer. Sixteen of the 24 patients were able to perform the exercise test (Group I), whilst the other eight were not (group II). Arterial blood gases and lung function tests were normal for both groups. Respiratory muscle strength as assessed both by maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) was significantly reduced (MIP 18-76 cmH2O; MEP 16-82 cmH2O) compared to predicted values. Inspiratory muscle endurance time was significantly reduced in Group II in comparison to Group I (247 +/- 148 vs 397 +/- 154 s, respectively). Both MIP and MEP were significantly related to inspiratory muscle endurance time. Endurance time, MIP and MEP were inversely significantly related to duration of illness, whilst only endurance time was significantly related to Expanded Disability Scale Score.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8143827     DOI: 10.1183/09031936.94.07010023

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Ventilatory impairment in the dysmyelinated Long Evans shaker rat.

Authors:  R A Johnson; T L Baker-Herman; I D Duncan; G S Mitchell
Journal:  Neuroscience       Date:  2010-06-11       Impact factor: 3.590

2.  Feasibility and Impact of an 8-Week Integrative Yoga Program in People with Moderate Multiple Sclerosis-Related Disability: A Pilot Study.

Authors:  Evan T Cohen; David Kietrys; Susan Gould Fogerite; Mariella Silva; Kristen Logan; Donald A Barone; J Scott Parrott
Journal:  Int J MS Care       Date:  2017 Jan-Feb

Review 3.  Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Martin Langeskov-Christensen; Martin Heine; Gert Kwakkel; Ulrik Dalgas
Journal:  Sports Med       Date:  2015-06       Impact factor: 11.136

4.  Physical inactivity, neurological disability, and cardiorespiratory fitness in multiple sclerosis.

Authors:  R W Motl; M Goldman
Journal:  Acta Neurol Scand       Date:  2011-02       Impact factor: 3.209

Review 5.  Exercise and multiple sclerosis.

Authors:  Lesley J White; Rudolph H Dressendorfer
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

6.  Cervical spinal demyelination with ethidium bromide impairs respiratory (phrenic) activity and forelimb motor behavior in rats.

Authors:  N L Nichols; A M Punzo; I D Duncan; G S Mitchell; R A Johnson
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

Review 7.  Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders.

Authors:  Rebecca A Johnson; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-28       Impact factor: 1.931

Review 8.  Respiratory muscle training for multiple sclerosis.

Authors:  Marc B Rietberg; Janne M Veerbeek; Rik Gosselink; Gert Kwakkel; Erwin Eh van Wegen
Journal:  Cochrane Database Syst Rev       Date:  2017-12-21

9.  Pulmonary Function and Respiratory Muscle Strength in Patients with Multiple Sclerosis.

Authors:  Elisabeth Westerdahl; Martin Gunnarsson; Anna Wittrin; Ylva Nilsagård
Journal:  Mult Scler Int       Date:  2021-06-14

10.  Lung volume recruitment in multiple sclerosis.

Authors:  Nadim Srour; Carole LeBlanc; Judy King; Douglas A McKim
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.